диссертации / 124
.pdf111
181. Rimm E.B. Prospective study of alcohol consumption and risk of coronary disease in men / E.B. Rimm, E.L. Giovannucci, W.C. Willett et al. // Lancet. – 1991. – № 338. – Р. 464–468.
182.Ritter M. Silent brain infarcts / M. Ritter, R. Dittrich, E. Ringelstein // Nervenarzt. – 2011. Vol. 82, № 8. – P. 1043–1052.
183.Rosano C. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults / C. Rosano, J. Brach, W.T. Longstreth, A.B. Newman // Neuroepidemiology. – 2006. – № 26. – Р. 52–60.
184.Rosano C. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults / C. Rosano, L.H. Kuller, H. Chung, A.M. Arnold, W.T. Longstreth, A.B. Newman // J. Am. Geriatr. Soc. – 2005. – № 53. – Р. 649–654.
185.Rothrock J.F. Brain magnetic resonance imaging in the evaluation of lacunar stroke / J.F. Rothrock, P.D. Lyden, J.R. Hesselink, J.J. Brown, M.E. Healy // Stroke. – 1987. – № 18. – Р. 781–786.
186.Sabetai M.M. Carotid plaque echogenicity and types of silent CT-brain infarcts. Is there an association in patients with asymptomatic carotid stenosis? / M.M. Sabetai, T.J. Tegos, C. Clifford // Int Angiol. – 2001 – Vol. 20, № 1. – Р. 51–57.
187.Sacco R.L. Physical activity and metabolism: an updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association. American Stroke Association / R.L. Sacco, S.E. Kasner, J.P. Broderick // Stroke. – 2013. – № 44. – Р. 2064–2089.
188.Saji N. Increased brachial ankle pulse wave velocity is independently associated with white matter hyperintensities / N. Saji, H. Shimizu, T. Kawarai, M. Tadano, Y. Kita, K. Yokono // Neuroepidemiology. – 2011. – № 36. – Р. 252–257.
112
189.Sasaki M. Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: a multicenter observer performance study / M. Sasaki, T. Hirai, T. Taoka // Neuroradiology. – 2008. – Vol. 50, № 9. – Р. 753–758.
190.Sato H. Aspirin attenuates the incidence of silent brain lesions in patients with nonvalvular atrial fibrillation / H. Sato, Y. Koretsune, M. Fukunami et al. // Circ. J. – 2004. – № 68. – Р. 410–416.
191.Scheltens P. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging / P. Scheltens, F. Barkhof,
D. Leys, J. Pruvo, J. Nauta, P. Vermersch, M. Steinling, J. Valk // J. Neurol. Sci. –
1993. – № 114. – Р. 7–12.
192.Schmidt R. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease. Results of the Austrian Stroke Prevention Study / R. Schmidt, H. Schmidt, M. Pichler et al. // Stroke. – 2006. – № 37. – Р. 2910–2916.
193.Schmidt W.P. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population / W.P. Schmidt, A. Roesler, K. Kretzschmar, K.H. Ladwig, R. Junker, K. Berger // J. Am. Geriatr. Soc. – 2004. – № 52. – Р. 1045–1050.
194.Serizawa M. Association between PRKCH gene polymorphisms and subcortical silent brain infarction / M. Serizawa, T. Nabika, Y. Ochiai et al. // Atherosclerosis. – 2008. – № 199. – Р. 340–345.
195.Shima H. Decreased kidney function is significant factor associated with cerebral infarction and periventicularhy erintensities / H. Shima, E. Ishimira, T. Naganuma // Kidney. Blood. Press. Res. – 2011. – Vol. 34, № 6. – Р. 430–438.
196.Shimada K. Silent cerebrovascular disease in the elderly: correlation
with ambulatory pressure / K. Shimada, A. Kawamoto, K. Matsubayashi,
T. Ozawa // Hypertension. – 1990. – № 16. – Р. 692–699.
113
197.Shinkawa A. Silent cerebral infarction in a community-based autopsy series in Japan / A. Shinkawa, K. Ueda, Y. Kiyohara et al. // The Hisayama Study. Stroke. – 1995. – № 26. – Р. 380–385.
198.Shinoda–Tagawa T. A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with type II diabetes / T. Shinoda–Tagawa, Y. Yamasaki, S. Yoshida, Y. Kajimoto, T. Tsujino, N. Hakui //
Diabetologia. – 2002. – № 45. – Р. 188–194.
199. Skoog I. A population-based study of dementia in 85-year-olds / I. Skoog, L. Nilsson, B. Palmertz et al. // N. Engl. J. Med. – 1993. – Vol. 328. –
P.153–158.
200.Song I.U. Clinical significance of silent cerebral infarctions in patients with Alzheimer disease / I.U. Song, J.S. Kim, Y.I. Kim // Cogn. Behav. Neurol. –
2007. – Vol. 20, № 2. – Р. 93–98.
201. Song Y.M. Distinct location of subcortical silent infarcts compared with symptomatic lacunar infarcts / Y.M. Song // J. Neurol. Sci. – 2009. – Vol. 287, № 1–2. – Р. 197–199.
202.Stein J.H. Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment / J.H. Stein, P.E. McBride // Arch. Intern. Med. – 1998. – № 158. – Р. 1301–1306.
203.Sugiyama T. Influence of treated blood pressure on progression of silent cerebral infarction / T. Sugiyama, J.D. Lee, H. Shimizu, S. Abe, T. Ueda // J. Hypertens. – 1999. – № 17. – Р. 679–684.
204.Takashima Y. Sex differences in the risk profile and male predominance in silent brain infarction in community-dwelling elderly subjects: the Sefuri brain MRI study / Y. Takashima, Y. Miwa, T. Mori et al. // Hypertens Res. –
2010. – № 33. – Р. 748–752.
114
205.Third Canadian Consensus Conference on Diagnosis and Treatment of Dementia, Alzheimer's & Dementia / The Journal of the Alzheimer's Association // 2007. – Vol. 3. – Issue 4.
206.Thong J.Y. Association of silent lacunar infarct with brain atrophy and cognitive impairment / J.Y. Thong, S. Hilal, Y. Wang // J. Neurol Neurosurg Psychiatry. – 2013. – Vol. 84, № 11. – Р. 1219–1225.
207.Tomohide A. Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke / A. Tomohide, K. Shotai, Y. Shuhei // Intern. Med. – 2002. – Vol. 41, № 2. – Р. 103–108.
208.Topper J.N. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress / J.N. Topper, J. Cai, D. Falb, M.A.Jr. Gimbrone // Proc. Natl. Acad. Sci. USA. – 1996. – № 93. – Р. 10417–10422.
209.Uehara T. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia / T. Uehara, M. Tabuchi, E. Mori // Stroke. – 1999. –
№30. – Р. 378–382.
210.Uekita K. Prevalence of cervical and cerebral atherosclerosis and silent brain infarction in patients with multivessel coronary artery disease / K. Uekita, N. Funayama, T. Nishiura, N. Makiguchi, N. Sakamoto // J. Cardiol. – 2001. – Vol. 38, 1. – Р. 13–20.
211.Uekita K. Cervical and intracranial atherosclerosis and silent brain infarction in Japanese patients with coronary artery disease / K. Uekita, N. Hasebe, N. Funayama et al. // Cerebrovasc Dis. – 2003. – № 16. – Р. 61–68.
212.Van Dijk E.J. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study / Van E.J. Dijk, N.D. Prins, S.E. Vermeer et al. // Circulation. – 2005. – № 112. – Р. 900–905.
115
213. Van Dijk E.J. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study / Van E.J. Dijk, N.D. Prins, H.A. Vrooman, A. Hofman, P.J. Koudstaal, M.M. Breteler // Stroke. – 2008. – № 39. – Р. 2712–2719.
214.Van Rijn M.J. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk / Van M.J. Rijn, M.J. Bos, M. Yazdanpanah et al. // Stroke. – 2006. – № 37. – Р. 2930–2934.
215.Van Swieten J. Grading white matter lesions on CT and MRI: a simple scale / Van J. Swieten, A. Hijdra, P. Koudstaal, van J. Gijn // J. Neurol Neurosurg Psychiatry. – 1990. – № 53. – Р. 1080–1083.
216.Vermeer S. Silent brain infarcts: a systematic review / S. Vermeer, W.Jr. Longstreth, P. Koudstaal // Lancet Neurol. – 2007. – № 6. – Р. 611–619.
217.Vermeer S., Prins N., den Heijer T. et al. Silent brain infarcts and the risk of dementia and cognitive decline / S. Vermeer, N. Prins, den T. Heijer et al. // N. Engl. J. Med. – 2003. – Vol. 348. – P. 1215–1222.
218.Vermeer S.E. Incidence and risk factors of silent brain infarcts in the popu- lation-based Rotterdam Scan Study / S.E. Vermeer, Den T. Heijer, P.J. Koudstaal, M. Oudkerk, A. Hofman, M.M.В. Breteler // Stroke. – 2003. – № 34. – Р. 392–396.
219.Vermeer S.E. Silent brain infarcts and white-matter lesions increase stroke risk in the general population: the Rotterdam Scan study / S.E. Vermeer,
M. Hollander, van E.J. Dijk, A. Hofman, P.J. Koudstaal, M.M.B. Breteler // Stroke. – 2003. – № 34. – Р. 1126–1129.
220. Vermeer S.E. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan study / S.E. Vermeer, P.J. Koudstaal, M. Oudkerk, A. Hofman, M.M.B. Breteler // Stroke. – 2002. –№ 33. – Р. 21–25.
116
221.Vermeer S.E. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study / S.E. Vermeer, van E.J. Dijk, P.J. Koudstaal et al. // Ann Neurol. – 2002. – № 51. – Р. 285–289.
222.Vítek L. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels / L. Vítek, M. Jirsa, M. Brodanová // Atherosclerosis. – 2002. – № 160. – Р. 449–456.
223.Wada H. Risk factors of aspiration pneumonia in Alzheimer‘s disease patients / H. Wada, K. Nakajoh, T. Satoh–Nakagawa et al. // Gerontology. –
2001. – № 47. – Р. 271–276.
224.Wada M. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly / M. Wada, H. Nagasawa, C. Iseki et al. // J. Neurol. Sci. – 2008. – № 272. – Р. 36–42.
225.Wadley V.G. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the reasons for geographic and racial differences in stroke (REGARDS) Study / V.G. Wadley, L.A. McClure, V.J. Howard, F.W. Unverzagt et al. // Stroke. – 2007. – Vol. 38, № 4. – Р. 1143–1147.
226.Wahlund L.O. A new rating scale for agerelated white matter changes applicable to MRI and CT / L.O. Wahlund, F. Barkhof, F. Fazekas et al. // Stroke. –
2001. – № 32. – Р. 1318–1322.
227. Waldstein S.R. Stress-induced blood pressure reactivity and silent cerebrovascular disease / S.R. Waldstein, E.L. Siegel, D. Lefkowitz et al. // Stroke. – 2004. – № 35. – Р. 1294–1298.
228. Wardlaw J. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration / J. Wardlaw, E. Smith,
А. Biessels // Lancet Neurol. – 2013. – Vol. 12, № 8. – P. 822–838.
117
229.Wolf A. Dietary l-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans / A. Wolf, C. Zalpour, G. Theilmeier et al. // J. Am. Coll. Cardiol. – 1997. – № 29. – Р. 479–485.
230.Wu R.H. Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors / R.H. Wu, Q. Li, Y. Tan // Neurol Sci. – 2014. – Vol. 35, № 10. – Р. 1553–1559.
231.Yamashita K. Cigarette smoking and silent brain infarction in normal adults / K. Yamashita, S. Kobayashi, S. Yamaguchi, H. Koide // Intern Med. –
1996. – № 35. – Р. 704–706.
232.Yasuhiro H. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the perindopril protection against recurrent stroke study (PROGRESS) CT Substudy in Japan / H. Yasuhiro, Y. Takenori, O. Teruo, W. Mark, C. John // Hypertens Res. – 2004. – Vol. 27, № 3.
233.Yi-Cheng Zhu. Silent Brain Infarcts. A review of MRI diagnostic criteria / Yi-Cheng Zhu, С. Dufouil, С. Tzourio, H. Chabriat // Stroke. – 2011. – № 42. –
Р. 1140–1145.
234.Ylikoski A. White matter hyperintensities on MRI in the neurologically
nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home / A. Ylikoski, T. Erkinjuntti, R. Raininko, S. Sarna, R. Sulkava, R. Tilvis // Stroke. – 1995. – № 26. – Р. 1171–1177.
235.Yoshida M. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP / M. Yoshida, K. Higashi, E. Kobayashi // Atherosclerosis.
–2010. – Vol. 211, № 2. – Р. 475–479.
236.Yoshida M. Acrolein, IL-6 and CRP as markers of silent brain infarction / M. Yoshida, H. Tomitori, Y. Machi // Atherosclerosis. – 2009. – Vol. 203,
№ 2. – Р. 557–562.
118
237. Zhang J.H. Genetic predisposition to neurological symptoms in lacunar infarction / J.H. Zhang, K. Kohara, Y. Yamamoto // Cerebrovasc Dis. – 2004. – Vol. 17, № 4. – Р. 273–279.
238.Zhao J. Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients / J. Zhao, H. Tang, J. Sun // Metab. Brain. Dis. – 2012. – Vol. 27, № 1. – Р. 17–22.
239.Zhefeng Q. The influences of silent cerebral infarction and hypertension on
brain atrophy in normal adults / Q. Zhefeng, H. Bokura, K. Iijima, H. Oguro,
S.Yamaguchi // Nihon Ronen Igakkai Zasshi. – 2008. – Vol. 45, № 2. – Р. 175–181.
241.Zhu Y.C. Silent brain infarcts: a review of MRI diagnostic criteria /
Y.C. Zhu, C. Dufouil, C. Tzourio, H. Chabriat // Stroke. – 2011. – № 42. –
Р. 1140–1145.